Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Chrysobalanaceae
Discrepant findings in immune responses to JC virus in patients receiving natalizumab.
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer.
Meprobamate
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Discrepant findings in immune responses to JC virus in patients receiving natalizumab.
Discrepant findings in immune responses to JC virus in patients receiving natalizumab. Lancet Neurol. 2010 Jun; 9(6):565-6; author reply 566-7.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antigens
Humans
Immunologic Factors
Interferon-beta
JC Virus
Multiple Sclerosis
Natalizumab
T-Lymphocytes
authors with profiles
Igor Koralnik